Skip to main content

Committees hear from academics in Coronavirus: lessons learnt inquiry

29 October 2020

The Science and Technology Committee and Health and Social Care Committees are holding their third public evidence session as part of their Coronavirus: lessons learnt inquiry.

This session will focus on treatments that can be used for COVID-19, including repurposed therapeutics. There will also be a focus on the development of vaccines for COVID-19 and the UK’s preparations for the roll-out of a future vaccine.

Witnesses

Wednesday 4 November - remote participation by witnesses and Committee members

Panel one (at 9.30am) 

  • Professor Peter Horby, Professor of Emerging Infectious Diseases and Global Health, University of Oxford

 

Panel two (at approx. 10.15am) 

  • Professor Andrew Pollard, Trial Chief Investigator, University of Oxford; and
  • Professor Robin Shattock, Chair in Mucosal Infection and Immunity, Imperial College London

 

Panel three (at approx. 11.00am)

  • Professor Wei Shen Lim, Chair, COVID-19 Panel, Joint Committee on Vaccination and Immunisation; and
  • Kate Bingham, Chair, UK Vaccine Taskforce

The inquiry

The Science and Technology Committee and Health and Social Care Committee’s joint inquiry into Coronavirus: lessons learnt was launched on Thursday 8 October. Evidence sessions will be chaired alternately by Committee Chairs Greg Clark for Science and Technology and Jeremy Hunt for Health and Social Care. Greg Clark will chair Wednesday’s evidence session.

Further information

Image: Pixabay